Eric McIntyre | Head, IR |
Todd Watanabe | President, CEO & Director |
Kenneth Lock | Chief Commercial Officer |
Patrick Burnett | SVP & Chief Medical Officer |
Scott Burrows | CFO & Principal Accounting Officer |
Kenneth Cacciatore | Cowen |
Vikram Purohit | Morgan Stanley |
Louise Chen | Cantor Fitzgerald |
Serge Belanger | Needham & Company |
Seamus Fernandez | Guggenheim Securities |
Gregory Fraser | Truist Securities |
Uy Ear | Mizuho Group |
Good day, and thank you for standing by. Welcome to the Arcutis Biotherapeutics, Inc. Q3 2022 Earnings Conference Call. [Operator Instructions].
I would now like to hand over the conference to your first speaker today, Eric McIntyre, Head of Investor Relations.